We are live on ! Find out more
HP

Harbourvest Partners Portfolio holdings

AUM $101M
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+2.47%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$181M
AUM Growth
-$26.2M
Cap. Flow
-$30M
Cap. Flow %
-16.54%
Top 10 Hldgs %
100%
Holding
23
New
2
Increased
1
Reduced
4
Closed
14

Top Buys

Rank Stock Value
1
RRC icon
Range Resources
RRC
+$9.58M
2
W icon
Wayfair
W
+$2.66M
3
EDIT icon
Editas Medicine
EDIT
+$745K

Top Sells

Rank Stock Value
1
CDW icon
CDW
CDW
+$30.4M
2
FIVN icon
FIVE9
FIVN
+$2.25M
3
SAGE
Sage Therapeutics
SAGE
+$1.28M
4
ETSY icon
Etsy
ETSY
+$1.25M
5
FMI
Foundation Medicine, Inc.
FMI
+$1.06M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 83.54%
2 Energy 5.07%
3 Financials 3.61%
4 Healthcare 3.42%
5 Industrials 0.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
W icon
1
Wayfair
W
$12.5B
$151M 83.54%
3,843,669
+65,835
+2% +$2.66M
RRC icon
2
Range Resources
RRC
$8.94B
$9.18M 5.07%
+236,920
New +$9.58M
FNJN
3
DELISTED
Finjan Holdings, Inc.
FNJN
$7.33M 4.05%
4,303,435
HAPN
4
Happen Inc
HAPN
$2.19B
$6.55M 3.61%
211,867
-25,820
-11% -$670K
SAGE
5
DELISTED
Sage Therapeutics
SAGE
$3.37M 1.86%
73,168
-31,400
-30% -$1.28M
TRVN
6
DELISTED
Trevena, Inc.
TRVN
$2.1M 1.16%
499
-102
-17% -$437K
SCTY
7
DELISTED
SolarCity Corporation
SCTY
$565K 0.31%
28,870
-36,884
-56% -$827K
EDIT icon
8
Editas Medicine
EDIT
$402M
$490K 0.27%
+36,362
New +$745K
ATRA icon
9
Atara Biotherapeutics
ATRA
$70.4M
$226K 0.12%
422
BOX icon
10
Box
BOX
$4.36B
-58,369
Closed -$604K
CDW icon
11
CDW
CDW
$18.4B
-758,318
Closed -$30.4M
CTMX icon
12
CytomX Therapeutics
CTMX
$701M
-10,000
Closed -$102K
ETSY icon
13
Etsy
ETSY
$8.21B
-129,819
Closed -$1.25M
FIVN icon
14
FIVE9
FIVN
$2.08B
-188,777
Closed -$2.25M
LRMR icon
15
Larimar Therapeutics
LRMR
$398M
-9,325
Closed -$670K
NTRA icon
16
Natera
NTRA
$36.1B
-87,418
Closed -$1.05M
RUN icon
17
Sunrun
RUN
$2.3B
-63,800
Closed -$390K
CMLS
18
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
-14,234
Closed -$35K
VRAY
19
DELISTED
ViewRay, Inc.
VRAY
-67,411
Closed -$276K
CARB
20
DELISTED
Carbonite Inc
CARB
-30,941
Closed -$301K
FMI
21
DELISTED
Foundation Medicine, Inc.
FMI
-56,567
Closed -$1.06M
ZLTQ
22
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
-33,862
Closed -$925K
MESG
23
DELISTED
XURA INC COM (DE)
MESG
-17,734
Closed -$433K

Similar funds

Harbourvest Partners's Q3 2016 Portfolio in Review

As of Q3 2016, Harbourvest Partners held 23 positions worth $181M, down 13% from $207M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Harbourvest Partners withdrew a net $30M in Q3 2016, closing 14 positions and reducing 4 holdings. Its most notable exit was CDW, an estimated $30.4M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 84% of assets, up from 72% a quarter earlier, followed by Energy and Financials.

Against the trend, Harbourvest Partners opened a new position in Range Resources worth $9.18M.

  • Harbourvest Partners's largest Q3 2016 buy was Range Resources: 236,920 shares worth $9.18M.
  • Harbourvest Partners added most to Wayfair in Q3 2016, an estimated $2.66M increase.
  • Harbourvest Partners's biggest Q3 2016 reduction was Sage Therapeutics, cutting an estimated $1.28M.
  • Harbourvest Partners fully exited CDW in Q3 2016, selling an estimated $30.4M.
  • Harbourvest Partners's ten largest holdings make up 100% of its $181M portfolio in Q3 2016.
  • Harbourvest Partners opened 2 new positions and closed 14 in Q3 2016.
  • Harbourvest Partners's portfolio value fell 13% quarter-over-quarter to $181M.

Based on Harbourvest Partners's 13F filing for Q3 2016, filed 14 Nov 2016.